Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib
Status:
Recruiting
Trial end date:
2023-10-29
Target enrollment:
Participant gender:
Summary
Multiparametric assesment of bone response in mCRPC patients treated with Cabozantinib upon
progression to chemotherapy and next generation hormonal agents: a phase II study